Bellevue Life Sciences Acquisition Corp. (BLAC)

BLAC Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.01	0.02	0.12	0	0.06
Cash & Short-Term Investments	0.01	0.02	0.12	0	0.06
Cash Growth	-78.89%	-87.62%	2517.22%	-92.41%	-
Prepaid Expenses	0.03	0.01	-	-	-
Total Current Assets	0.04	0.02	0.12	0	0.06
Long-Term Deferred Charges	-	-	1.1	0.7	0.26
Other Long-Term Assets	20.89	36.61	-	-	-
Total Assets	20.93	36.63	1.23	0.71	0.32
Accounts Payable	1.26	1.08	0.03	0	-
Accrued Expenses	0.53	0.36	-	-	-
Short-Term Debt	1.87	0.07	1.22	0.41	0.3
Current Income Taxes Payable	0.29	0.52	-	-	-
Other Current Liabilities	-	-	0.01	0.29	0.02
Total Current Liabilities	3.94	2.04	1.26	0.71	0.32
Other Long-Term Liabilities	22.74	38.5	-	-	-
Total Liabilities	26.68	40.53	1.26	0.71	0.32
Common Stock	0	0	0	0	0
Additional Paid-In Capital	-	-	0.02	0.02	0.02
Retained Earnings	-5.75	-3.91	-0.06	-0.03	-0.02
Shareholders' Equity	-5.75	-3.91	-0.04	-0	0
Total Liabilities & Equity	20.93	36.63	1.23	0.71	0.32
Total Debt	1.87	0.07	1.22	0.41	0.3
Net Cash (Debt)	-1.85	-0.06	-1.09	-0.41	-0.24
Net Cash Per Share	-0.34	-0.01	-0.73	-0.27	-0.16
Filing Date Shares Outstanding	4.04	5.62	9.06	1.5	1.5
Total Common Shares Outstanding	4.04	5.62	1.5	1.5	1.5
Working Capital	-3.9	-2.02	-1.14	-0.7	-0.26
Book Value Per Share	-1.42	-0.69	-0.03	-0.00	0.00
Tangible Book Value	-5.75	-3.91	-0.04	-0	0
Tangible Book Value Per Share	-1.42	-0.69	-0.03	-0.00	0.00

Source: S&P Capital IQ. Standard template. Financial Sources.